Econazole updated on 01-29-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Cleft lip with or without cleft palate1.85 [0.42, 8.18]0%2 studies2,46022not evaluable ROB-
Congenital heart defects2.50 [0.97, 6.43]1%2 studies7,52826not evaluable ROB-
Hypospadias2.79 [0.96, 8.13]0%2 studies3,81424not evaluable ROB-
Neural Tube Defects2.97 [0.77, 11.52]0%2 studies1,95222not evaluable ROB-
All congenital malformations (majors, minors, majors and minors, or unspecified)1.40 [0.69, 2.85]-1 study22,84334not evaluable ROB-
Ano-rectal atresia and stenosis7.63 [0.31, 187.87]-1 study2091not evaluable ROB-
Bilateral renal agenesis including Potter syndrome9.45 [0.57, 157.50]-1 study10419not evaluable ROB-
Club foot / Talipes equinovarus0.90 [0.11, 7.42]-1 study2,42420not evaluable ROB-
Craniosynostosis3.56 [0.14, 87.59]-1 study4471not evaluable ROB-
Diaphragmatic hernia5.80 [0.24, 142.60]-1 study2751not evaluable ROB-
Gastroschisis3.50 [0.14, 86.05]-1 study4551not evaluable ROB-
Major congenital malformations1.40 [0.69, 2.85]-1 study22,84334not evaluable ROB-
Polydactyly1.10 [0.12, 9.90]-1 study1,74420not evaluable ROB-

Hide endpoints reported in only one study ...